Showing 121-130 of 5121 results for "".
DermWireTV: PCA to Space Station; ASDS Pandemic Data; LaRoche-Posay, GW Partnership
https://practicaldermatology.com/topics/practice-management/dermwiretv-pca-to-space-station-asds-pandemic-data-laroche-posay-gw-partnership/20059/The "Great Resignation" forcing some dermatology practices to operate with reduced staffing is just one of the lingering impacts of the COVID-19 pandemic on practices, according to results of a survey by the American Society for Dermatologic Surgery. PCA skin is sending the first-ever private sectorDermWireTV: Galderma Gets Cheeky, COVID Vax & Skin, AKN Classification
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-gets-cheeky-covid-vax-skin-akn-classification/19955/Only a small percentage of patients have skin reactions to COVID-19 vaccines, but true allergic reactions must be identified. FDA approves Restylane Contour from Galderma. New classification may aid treatment selection or acne keloidalis.Removing Obstacles to Dermatologic Care for LGBTQ/GSM Patients
https://practicaldermatology.com/topics/practice-management/removing-obstacles-to-dermatologic-care-for-lgbtqgsm-patients/19935/Members of gender and sexual minority groups may feel less comfortable seeking healthcare than their non-LGBTQ/GSM counterparts. Klint Peebles, MD addresses some of the barriers to access and offers strategies for building more inclusive and welcoming dermatology practices.Microneedling - The essential gateway technology for your growing practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/microneedling-the-essential-gateway-technology-for-your-growing-practice/19809/In this webinar, Lesley Clark-Loeser, MD, FAAD discusses microneedling, its growth in the industry and why every practice should offer the gateway technology. Dr. Clark-Loeser discusses the latest microneedling device introduced into her practice – the Exceed™ medical microneedling device – and thePsoriasis Update: Understanding the Latest Psoriasis Guidelines
https://practicaldermatology.com/topics/psoriasis/psoriasis-update-understanding-the-latest-psoriasis-guidelines/19777/In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of pThe Laser Graveyard
https://practicaldermatology.com/topics/practice-management/the-laser-graveyard/18548/If old devices are taking up space in your office, it's time to get rid of them. Consider donating them or even selling them. Buyer, beware, if you are considering buying a second-hand laser. They can be a good option for a practice looking to save money, but you may not get a warranty.Robert Grant Steps Down at Alphaeon; Skin Cancer Special Edition
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-robert-grant-steps-down-at-alphaeon-skin-cancer-special-edition/18595/Robert Grant is no longer CEO of lifestyle healthcare company Alphaeon. Mr. Grant founded Alphaeon in 2013 as a wholly owned subsidiary of Strathspey Crown LLC, a private equity firm located in Newport Beach, CA, where he serves as Chairman. Also in this issue, a closer look at skin cancer. May is SCynosure, Cutera Laser Clearances; Surgeon General Takes on Skin Cancer
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cynosure-cutera-laser-clearances-surgeon-general-takes-on-skin-cancer/19096/In this edition of DermWireTV, from the publishers of Practical Dermatology® and Modern Aesthetics® host Devyn Gehrit offers highlights of the annual summer meeting, explores a new skin cancer initiative by the Surgeon General, and covers FDA clearances for Cynosure and Cutera laser systems.GEP Testing for Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/series/updates-in-skin-cancer/gep-testing-for-cutaneous-squamous-cell-carcinoma/35599/Emily Ruiz, MD, MPH, FAAD, director of the High-Risk Cancer Clinic at Dana-Farber Cancer Institute, discusses utilizing gene expression profiling (GEP) to risk stratify tumors in cutaneous squamous cell carcinoma patients.Practical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 2
https://practicaldermatology.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-2/32758/Host Neal Bhatia, MD, FAAD, and guests Laura K. Ferris, MD, PhD, FAAD, and Jason E. Hawkes, MD, MS, FAAD, discuss the differences between psoriasis subtypes, the importance of a specialized therapeutic approach targeting the IL-36 pathway for generalized pustular psoriasis, and the role of neutrophi